Interim report, May 1 - July 31, 2000/2001

Interim report, May 1 - July 31, 2000/2001 - Income before taxes amounted to a loss of SEK 18 M (loss: 68), an improvement of SEK 50 M. - Improved order bookings in all geographic markets. - Net sales, excluding divested IGS operations, increa-sed 25 percent. - Net sales of service rose 33 percent. - Continued positive cash flow. - Improved return on capital employed, at +4 percent (-22). For additional information, please call: Lars Jonsteg, Vice President, Corporate Relations, Elekta AB (publ), Tel.: +46 8-587 254 82 Additional information on Elekta is available on the Internet: ------------------------------------------------------------ This information was brought to you by Waymaker The following files are available for download: The full report

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,700 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm.


Documents & Links